LungLife AI, Inc (DI) (LLAI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 26.50
  • 52 Week Low: 0.90
  • Currency: UK Pounds
  • Shares Issued: 25.49m
  • Volume: 506,010
  • Market Cap: £0.89m

LLAI Overview

LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.

1 Day Chart (02-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -12243.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 25.7 n/a
Pr/Book 0.1  
Latest F'cast
Revenue 91.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

LLAI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.21 (4.84) (74.30)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.19 (7.43) (46.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.02 (7.60) (29.80)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.05 (5.41) (21.20)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

LLAI Company Announcements

Notice of Special Meeting 29-Apr-2025 07:00 RNS
License Agreement and Other Matters 17-Apr-2025 07:00 RNS
Change of Nominated Adviser and Joint Broker 10-Feb-2025 07:00 RNS

LLAI ShareCast News

Lunglife strikes strategic partnership with Circ... 17-Apr-2025 ShareCast
LungLife AI upbeat on progress with LungLB test 19-Nov-2024 ShareCast
LungLife test secures Medicare coverage determin... 16-Aug-2024 ShareCast

Latest LLAI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

LLAI Market Data

Currency UK Pounds
Share Price 3.50p
Change Today 0.50p
% Change 16.67 %
52 Week High 26.50
52 Week Low 0.90
Volume 506,010
Shares Issued 25.49m
Market Cap £0.89m

LLAI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.58% above the market average36.58% above the market average36.58% above the market average36.58% above the market average36.58% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Price Trend
97.38% below the market average97.38% below the market average97.38% below the market average97.38% below the market average97.38% below the market average
95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average
Income Not Available
Growth
3.29% below the market average3.29% below the market average3.29% below the market average3.29% below the market average3.29% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average

LLAI Dividends

No dividends found

Trades for 02-May-2025

Time Volume / Share Price
16:38 75,000 @ 3.42p
16:03 82,321 @ 3.64p
15:57 2,000 @ 3.37p
15:28 120,000 @ 3.75p
14:44 33,635 @ 3.55p

LLAI Key Personnel

CEO Paul Carmelo Pagano

Top of Page